Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis

NCT02197767 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Fibrillary Glomerulonephritis

Interventions

DRUG: rituximab

Sponsor

Mayo Clinic

Collaborators

[object Object]